Pioneering Biotechnology for Human Wellness
Platform Company
Invent · Scale · Commercialize Advanced Health Ingredients
Not single products — we own entire platform technologies.
From discovery to scalable industrial production.
Computational modeling and AI-assisted decision support.
Value creation across the entire value chain.
Mature Commercialization
Global commercialization platform for established, scalable functional ingredients. Taking proven technologies to global markets.
R&D · CRO · Novel Ingredients
Focused on proprietary R&D, CRO services, and incubation of next-generation ingredients and molecules. Where tomorrow's breakthroughs begin.
Consumer Products · Highest Value
Builds premium consumer wellness products based on science-backed, high-end ingredients. Capturing the highest value in the chain.
Industrial Acceleration
Regional innovation and industrial acceleration platform positioned close to key industry clusters, enabling rapid patent-to-process translation.
New molecule and novel ingredient conception. Proprietary R&D and CRO services. Patent- and IP-driven innovation pipelines.
Computational modeling, AI-assisted evaluation, and biomanufacturing expertise to reduce risk and accelerate iteration.
Early-stage process design, rapid patent-to-process translation, and industry-cluster-driven execution strategies.
Strategic minority investments in upstream partners to accelerate optimization and enable shared long-term value creation.
Ingredient platform commercialization, brand and channel ownership, market feedback driving upstream innovation.
"We set out to build something different — a platform that connects invention, industrial acceleration, and market ownership into one integrated system."
OHM was founded with a clear vision: to bridge the gap between scientific discovery and global market impact. By owning the entire value chain — from R&D and industrial translation to commercialization — we create lasting value in the health ingredients space.
Preston Liu envisions a platform company that connects invention, industrial acceleration, and market ownership — laying the foundation for OHM.
CTO 赵吉凯 (Jikai Zhao) joins the founding team, bringing deep expertise in biomanufacturing, data-driven process design, and R&D strategy.
Official launch of OHM as a platform holding company, unifying R&D, industrial capability, and commercial channels under one strategic umbrella.
First operating company launched, focused on global commercialization of established, scalable functional ingredients.
R&D and CRO services arm established, dedicated to proprietary research and incubation of next-generation ingredients.
Regional innovation and industrial acceleration platform established in Asia-Pacific, positioned close to key manufacturing clusters.
Premium consumer wellness brand launched, capturing the highest value in the chain with science-backed, high-end ingredient products.
Visionary leaders driving innovation from invention to global scale
Founder & CEO
Platform strategy, capital alignment & long-term value creation
Chief Technology Officer
R&D strategy, biomanufacturing pathways & data-driven process design
VP of Operations
Operations execution, industrial translation & supply coordination
SVP of Business Development
Strategic partnerships, technology collaboration & platform growth
VP of Sales
Global sales strategy, client relationships & revenue growth
Our advisory network spans synthetic biology, metabolic engineering, food science, AI/ML, and industrial operations—bridging discovery to commercial impact.
Professor
J. Craig Venter Institute
Professor
Chongqing University
Assistant Professor
UC Davis
Research Scientist
UIUC
Co-Pack Quality Manager
Talking Rain Beverage Company
Machine Learning Engineer
BMO
Head of Operations
Nuritas
R&D Director
Extrusion & Development
Strategic guidance on research direction and innovation priorities
Assessment of technical viability and scalability potential
Bridging academic, industrial, and commercialization resources